Page last updated: 2024-11-07

dichlororibofuranosylbenzimidazole and Colonic Neoplasms

dichlororibofuranosylbenzimidazole has been researched along with Colonic Neoplasms in 4 studies

Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.

Colonic Neoplasms: Tumors or cancer of the COLON.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Farah, M1
Parhar, K1
Moussavi, M1
Eivemark, S1
Salh, B1
Pautz, A1
Linker, K1
Hubrich, T1
Korhonen, R1
Altenhöfer, S1
Kleinert, H1
Krajci, P1
Taskén, K1
Kvale, D1
Brandtzaeg, P1
te Poele, RH1
Okorokov, AL1
Joel, SP1

Other Studies

4 other studies available for dichlororibofuranosylbenzimidazole and Colonic Neoplasms

ArticleYear
5,6-Dichloro-ribifuranosylbenzimidazole- and apigenin-induced sensitization of colon cancer cells to TNF-alpha-mediated apoptosis.
    American journal of physiology. Gastrointestinal and liver physiology, 2003, Volume: 285, Issue:5

    Topics: Antineoplastic Agents; Apigenin; Apoptosis; Casein Kinase II; Cell Division; Cell Line, Tumor; Cell

2003
The polypyrimidine tract-binding protein (PTB) is involved in the post-transcriptional regulation of human inducible nitric oxide synthase expression.
    The Journal of biological chemistry, 2006, Oct-27, Volume: 281, Issue:43

    Topics: Carcinoma; Cell Line; Cell Line, Tumor; Colonic Neoplasms; Cytokines; Dichlororibofuranosylbenzimida

2006
Interferon-gamma stimulation of messenger RNA for human secretory component (poly-Ig receptor) depends on continuous intermediate protein synthesis.
    Scandinavian journal of immunology, 1993, Volume: 37, Issue:2

    Topics: Colonic Neoplasms; Cycloheximide; Dactinomycin; Dichlororibofuranosylbenzimidazole; Humans; Interfer

1993
RNA synthesis block by 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) triggers p53-dependent apoptosis in human colon carcinoma cells.
    Oncogene, 1999, Oct-14, Volume: 18, Issue:42

    Topics: Adenocarcinoma; Apoptosis; Cell Survival; Clone Cells; Colonic Neoplasms; Dichlororibofuranosylbenzi

1999